Stocktoria
Solventum Corp SOLV
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2024-03-26
Chart by TradingView
6/9
Piotroski F — financial health
2.34
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $8.3B | $8.3B | $8.2B |
| Gross profit | $4.5B | $4.6B | $4.7B |
| Operating income | $2.2B | $1.0B | $1.7B |
| Net income | $1.6B | $479.0M | $1.3B |
| Operating cash flow | $369.0M | $1.2B | $1.9B |
| Free cash flow | -$10.0M | $805.0M | $1.6B |
| Total assets | $14.3B | $14.5B | $13.9B |
| Total liabilities | $9.2B | $11.5B | $2.3B |
| Shareholders' equity | $5.0B | $3.0B | $11.7B |
| Ratios | |||
| Gross margin | 53.5% | 55.6% | 57.3% |
| Operating margin | 26.2% | 12.6% | 20.6% |
| Net margin | 18.7% | 5.8% | 16.4% |
| FCF margin | -0.1% | 9.8% | 19.8% |
| Return on assets | 10.9% | 3.3% | 9.7% |
| Return on equity | 30.8% | 16.2% | 11.5% |
| Debt / equity | 1.00× | 2.64× | 0.00× |
| Current ratio | 1.23 | 1.20 | 1.46 |
| Revenue growth | 0.9% | 0.7% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Bridgewater Associates, LP | 3,378 | $220,583 |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.34 (grey)
- Working capital / assets 0.051
- Retained earnings / assets 0.126
- EBIT / assets 0.153
- Equity / liabilities 0.546
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001964738 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.